Diagnostic and Prognostic Value of Plasma Gelsolin in Multiorgan Failure in Patients with Sepsis

Ahmed El-Maghraby; Hossam Mowafy; Emad Omer; Hazem El-Akabawy; Iris Nessim

doi:10.3889/oamjms.2021.5281

Authors

Ahmed El-Maghraby Department of Critical Care Medicine, Theodor Bilharz Research Institute, Cairo, Egypt
Hossam Mowafy Department of Critical Care Medicine, Cairo University, Cairo, Egypt
Emad Omer Department of Critical Care Medicine, Cairo University, Cairo, Egypt
Hazem El-Akabawy Department of Critical Care Medicine, Cairo University, Cairo, Egypt
Iris Nessim Clinical Chemistry Unit, Theodor Bilharz Research Institute, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2021.5281

Keywords:

Gelsolin, Sepsis, Septic shock, Acute physiology and Chronic health Evaluation II, Sequential Organ Failure Assessment (SOFA) score

Abstract

AIM: The aim of this work is to investigate the clinical value of gelsolin plasma concentration in the diagnosis of sepsis and investigate the relationship between gelsolin plasma concentration and the severity of organ dysfunction assessed by the acute physiology and chronic health evaluation (APACHE II) and SOFA scores, and to study the mortality predictive power of gelsolin plasma concentration.

METHODS: We analyzed data of patients admitted with sepsis (n = 46) for 5 days. Age- and sex-matched non-specific intensive care unit (ICU) patients (n = 18) served as controls. Septic patients were then divided according to severity of disease to patients with sepsis, severe sepsis, and septic shock. Besides plasma gelsolin (pGSN) classical laboratory parameters and clinical scores (APACHE II and SOFA) were also assessed.

RESULTS: Septic patients showed significantly decreased 1^st-day GSN levels (170.9 ± 74.3 mg/l) compared to non-septic critically ill patients (225.9 ± 84.5 mg/l, p < 0.05). Furthermore, patients with septic shock had lower gelsolin plasma concentration than with severe sepsis and with sepsis (p < 0.05); furthermore, non-survivors had significantly lower GSN levels compared to survivors (p < 0.05). Septic patients had higher APACHE II and SOFA scores. Lower GSN level was significantly correlated with the development of multiple organ dysfunction syndrome and fatal outcome, also, patients with lower GSN level had longer ICU stay, APACHE II, and SOFA scores. APACHE II score has shown best ability to predict mortality with AUC 0.913 followed by PCT with AUC 0.828. pGSN was the least in the ability to predict mortality with AUC only 0.378 despite significant difference between pGSN levels between survivals and non-survivals.

CONCLUSIONS: pGSN might serve as efficient complementary marker in sepsis. However, the prognostic role of pGSN in mortality requires further investigation in larger studies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34(2):344-53. https://doi.org/10.1097/01.ccm.0000194725.48928.3a PMid:16424713

Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15-21.

PMid:16374151

Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial. JAMA. 2013;309(11):1154-62. https://doi.org/10.3410/f.717991612.793473478 PMid:23512062

Wang HE, Szychowski JM, Griffin R, Safford MM, Shapiro NI, Howard G. Long term mortality after sepsis. Chest. 2013;21(12):E762-9.

Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: A systematic review. Crit Care Med. 2010;38(5):1276-83. PMid:20308885

Janmey PA, Lind SE. Capacity of human serum to depolymerize actin filaments. Blood. 1987;70(2):524-30. https://doi.org/10.1182/blood.v70.2.524.bloodjournal702524 PMid:3038216

Kwiatkowski DJ, Mehl R, Izumo S, Nadal-Ginard B, Yin HL. Muscle is the major source of plasma gelsolin. J Biol Chern. 1988;263(17):8239-43. PMid:2836420

Lind SE, Smith DB, Janmey PA, Stossel TP. Role of plasma gelsolin and the Vitamin D-binding protein in clearing actin from the circulation. J Clin Invest. 1986;78(3):736-42. PMid:3018044

Goldschmidt-Clermont PJ, Van Baelen H, Bouillon R, Shook TE, Williams MH, Nel AE. Role of group specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit. J Clin Invest. 1988;81(5):1519-27. https://doi.org/10.1172/jci113484 PMid:3366905

Lee WM, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N Engl J Med. 1992;326(20):1335-41. https://doi.org/10.1056/nejm199205143262006 PMid:1314333

Lee WM, Reines D, Watt GN, Cook JA, Wise WC, Halushka PV, et al. Alterations in Gc protein levels and complexing in septic shock. Circ Shock. 1989;28(3):249-55. PMid:2766479

Smith DB, Janmey PA, Lind SE. Circulating actin-gelsolin complexes following oleic acid-induced lung injury. Am J Pathol. 1988;130(2):261-7. PMid:2829631

Dahl B, Schiodt FV, Ott P, Gvozdenovic R, Yin HL, Lee WM. Plasma gelsolin is reduced in trauma patients. Shock. 1999;12(2):102-4. https://doi.org/10.1097/00024382-199908000-00002 PMid:10446889

Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO. Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg. 2006;243(3):399-403. https://doi.org/10.1097/01.sla.0000201798.77133.55 PMid:16495706

Mounzer KC, Moncure M, Smith YR, Dinubile MJ. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med. 1999;160(5 Pt):1673-81. https://doi.org/10.1164/ajrccm.160.5.9807137 PMid:10556139

DiNubile MJ, Stossel TP, Ljunghusen OC, Ferrara JL, Antin JH. Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood. 2002;100(13):4367- 71. https://doi.org/10.1182/blood-2002-06-1672 PMid:12393536

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250-6. https://doi.org/10.1007/s00134-003-1662-x PMid:12682500

Horváth-Szalai Z, Kustán P, Mühl D, Ludány A, Bugyi B, Kőszegi T. Antagonistic sepsis markers: Serum gelsolin and actin/gelsolin ratio. The Canadian society of clinical chemists. Clin Biochem J 2017;50(3):127-33. https://doi.org/10.1016/j.clinbiochem.2016.10.018 PMid:27823961

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29. https://doi.org/10.1097/00003246-198510000-00009 PMid:3928249

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707-10. https://doi.org/10.1007/ bf01709751 PMid:8844239

Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-54. PMid:12700374

Annane D, Aegerter P, Jars-Guincestre MC, Guidet B; CUB-Réa Network. Current epidemiology of septic shock: The CUBRea Network. Am J Respir Crit Care Med. 2003;168(2):165-72. https://doi.org/10.1164/rccm.2201087 PMid:12851245

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-77. https://doi.org/10.1056/nejmoa010307 PMid:11794169

Levy MM, Macias WL, Vincent JL, Russell JA, Silva E, Trzaskoma B, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005;33(10):2194-201. https://doi.org/10.1097/01.ccm.0000182798.39709.84 PMid:16215369

Giuliano KK. Physiological monitoring for critically ill patients: Testing a predictive model for the early detection of sepsis. Am J Crit Care. 2007;16(2):122-30; quiz 131. https://doi.org/10.4037/ajcc2007.16.2.122 PMid:17322011

Liu A, Bui T, Van Nguyen H, Ong B, Shen Q, Kamalasena D. Serum C-reactive protein as a biomarker for early detection of bacterial infection in the older patient. Age Ageing. 2010;39(5):559-65. https://doi.org/10.1093/ageing/afq067 PMid:20573779

Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009;37(1):96-104. https://doi.org/10.1097/ccm.0b013e318192fd9d PMid:19050610

Wilson JX, Young GB. Sepsis-associated encephalopathy: Evolving concepts. Neurol J Southeast Asia 2003;8:65-76.

Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. What is the best method for estimating the burden of severe sepsis in the United States? J Crit Care. 2012;27(4):414.e1-9. https://doi.org/10.1186/cc14095 PMid:22516143

Melville J, Ranjan S, Morgan P. ICU mortality rates in patients with sepsis before and after the Surviving Sepsis Campaign. Crit Care. 2015;19(Suppl 1):P15. https://doi.org/10.1186/cc14095

Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-8. https://doi.org/10.1001/jama.286.14.1754 PMid:11594901

Liu B, Chen YX, Yin Q, Zhao YZ. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013;17(5):R244. https://doi.org/10.1186/cc13070 PMid:24138799

Yousef AA, Suliman GA. The predictive prognostic values of serum TNF-alpha in comparison to SOFA score monitoring in critically ill patients. Biomed Res Int 2013;2013:258029. https://doi.org/10.1155/2013/258029 PMid:24175285

Daviaud F, Grimaldi D, Dechartres A, Charpentier J, Geri G, Marin N, et al. Timing and causes of death in septic shock. Ann Intensive Care. 2015;5(1):16. PMid:26092499

Suhler E, Lin W, Yin HL, Lee WM. MD Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med. 1997;25(4):594-8. https://doi.org/10.1097/00003246-199704000-00007 PMid:9142022

Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med. 2007;35(3):849-55. https://doi.org/10.1097/01.ccm.0000253815.26311.24 PMid:17205019

Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB. Plasma gelsolin depletion and circulating actin in sepsis a pilot study. PLoS One. 2008;3(11):e3712. https://doi.org/10.1371/journal.pone.0003712 PMid:19002257

Cohen TS, Bucki R, Byfield FJ, Ciccarelli NJ, Rosenberg B, DiNubile MJ, et al. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cytokine. 2011;54(3):235-8. https://doi.org/10.1016/j.cyto.2011.02.006 PMid:21420877

Wang H, Cheng B, Chen Q, Wu S, Lv C, Xie GH, et al. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care. 2008;12(4):R106. https://doi.org/10.1186/cc6988 PMid:18706105

Huang LF, Yao YM, Li JF, Dong D, Liu C, Yu Y, et al. Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients. PLoS One. 2011;6(11):e25748. https://doi.org/10.1371/journal.pone.0025748

Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, et al. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol. 2009;20(5):1140- 8. https://doi.org/10.1681/asn.2008091008 PMid:19389844